Backabrdn Life Sciences Investors Overview

abrdn Life Sciences Investors Other Current Liabilities

Latest other current liabilities for HQL: $0.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$0.00

Peer trimmed avg / median

Loading

abrdn Life Sciences Investors Other Current Liabilities History

Loading

abrdn Life Sciences Investors vs. peers: Other Current Liabilities Comparison

Loading

abrdn Life Sciences Investors Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

abrdn Life Sciences Investors (HQL) FAQ

As of the most recent data (March 2026), HQL shows a other current liabilities of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQL's other current liabilities is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Life Sciences Investors is outperforming or lagging.

Tracking HQL's other current liabilities over time shows whether abrdn Life Sciences Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has abrdn Life Sciences Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $0) with ownership activity and broader fundamentals.